Algert Global LLC Purchases New Shares in The Chemours Company (NYSE:CC)

Algert Global LLC purchased a new stake in The Chemours Company (NYSE:CC - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 186,190 shares of the specialty chemicals company's stock, valued at approximately $3,147,000. Algert Global LLC owned about 0.12% of Chemours as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC boosted its position in shares of Chemours by 99.7% in the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company's stock worth $26,000 after purchasing an additional 765 shares during the last quarter. Quadrant Capital Group LLC boosted its holdings in Chemours by 100.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 1,119 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of Chemours during the 4th quarter worth about $48,000. Itau Unibanco Holding S.A. increased its stake in shares of Chemours by 39.3% in the 4th quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company's stock valued at $60,000 after acquiring an additional 1,003 shares during the last quarter. Finally, KBC Group NV raised its position in shares of Chemours by 38.2% in the 4th quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company's stock valued at $104,000 after acquiring an additional 1,708 shares during the period. Institutional investors and hedge funds own 76.26% of the company's stock.

Wall Street Analyst Weigh In

CC has been the subject of several recent analyst reports. Truist Financial lowered their target price on shares of Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a research note on Monday, April 14th. StockNews.com downgraded Chemours from a "hold" rating to a "sell" rating in a research note on Thursday. Morgan Stanley decreased their target price on Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Mizuho set a $15.00 price target on Chemours in a research report on Tuesday, April 15th. Finally, Barclays cut their price objective on Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $19.11.

Chemours Stock Down 1.1 %

Shares of CC stock traded down $0.12 during trading on Friday, reaching $11.12. The company's stock had a trading volume of 7,192,895 shares, compared to its average volume of 1,962,638. The Chemours Company has a one year low of $9.33 and a one year high of $29.21. The business has a fifty day moving average price of $12.55 and a 200-day moving average price of $16.52. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 19.51 and a beta of 1.76. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The company had revenue of $1.37 billion during the quarter, compared to the consensus estimate of $1.36 billion. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.32 earnings per share. Analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.25 per share. The ex-dividend date was Friday, February 28th. This represents a $1.00 annualized dividend and a dividend yield of 8.99%. Chemours's dividend payout ratio is currently 500.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.